By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical steroids > Clobetasol > Clobetasol Topical Dosage
Topical steroids
https://themeditary.com/dosage-information/clobetasol-topical-dosage-224.html

Clobetasol Topical Dosage

Drug Detail:Clobetasol (Clobetasol topical [ kloe-bay-ta-sol ])

Drug Class: Topical steroids

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Dermatitis

  • Solution, spray, ointment, gel, foam, lotion, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely.
  • Shampoo: Apply to dry scalp once a day in a thin film to the affected areas only and leave in place for 15 minutes before lathering and rinsing.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fluid ounce) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Relief of corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Adult Dose for Eczema

  • Solution, spray, ointment, gel, foam, lotion, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely.
  • Shampoo: Apply to dry scalp once a day in a thin film to the affected areas only and leave in place for 15 minutes before lathering and rinsing.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fluid ounce) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Relief of corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Adult Dose for Psoriasis

  • Solution, spray, ointment, gel, foam, lotion, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely.
  • Shampoo: Apply to dry scalp once a day in a thin film to the affected areas only and leave in place for 15 minutes before lathering and rinsing.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fluid ounce) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Relief of corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Adult Dose for Dermatological Disorders

  • Solution, spray, ointment, gel, foam, lotion, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely.
  • Shampoo: Apply to dry scalp once a day in a thin film to the affected areas only and leave in place for 15 minutes before lathering and rinsing.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fluid ounce) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Relief of corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Adult Dose for Lichen Planus

  • Solution, spray, ointment, gel, foam, lotion, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely.
  • Shampoo: Apply to dry scalp once a day in a thin film to the affected areas only and leave in place for 15 minutes before lathering and rinsing.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fluid ounce) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Relief of corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Pediatric Dose for Dermatitis

  • Solution, ointment, gel, foam, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely. Not recommended for use in children under 12 years of age.
  • Shampoo, spray, and lotion formulations: Not recommended for use in children under 18 years of age.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Pediatric Dose for Eczema

  • Solution, ointment, gel, foam, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely. Not recommended for use in children under 12 years of age.
  • Shampoo, spray, and lotion formulations: Not recommended for use in children under 18 years of age.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Pediatric Dose for Psoriasis

  • Solution, ointment, gel, foam, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely. Not recommended for use in children under 12 years of age.
  • Shampoo, spray, and lotion formulations: Not recommended for use in children under 18 years of age.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Pediatric Dose for Dermatological Disorders

  • Solution, ointment, gel, foam, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely. Not recommended for use in children under 12 years of age.
  • Shampoo, spray, and lotion formulations: Not recommended for use in children under 18 years of age.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Usual Pediatric Dose for Lichen Planus

  • Solution, ointment, gel, foam, cream formulations: Apply a thin layer to affected areas twice a day and rub in gently and completely. Not recommended for use in children under 12 years of age.
  • Shampoo, spray, and lotion formulations: Not recommended for use in children under 18 years of age.

Maximum dose: The total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week.

Duration of therapy: Treatment should be limited to 2 consecutive weeks for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and up to 2 additional weeks in localized lesions (less than 10% body surface area) of moderate to severe plaque psoriasis that
have not improved after the initial 2 weeks of treatment.

Comments: Unless directed by a healthcare professional, this drug should not be used with occlusive dressings.

Uses:
  • Corticosteroid-responsive inflammatory and pruritic dermatoses; psoriasis; recalcitrant eczemas, lichen planus, discoid lupus erythematosus, and other conditions which do not respond satisfactorily to less active steroids.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to any of the ingredients

  • If treatment is required for use in children, it is recommended that it should be reviewed weekly.

Safety and efficacy have not been established in patients younger than 18 years and its use in pediatric patients under 12 years of age is not recommended.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Do not use on your face, groin, armpits, lips, or in your eyes.
  • Do not cover your head with a shower cap or bathing cap.
  • Wash your hands after applying the drug unless it is the hands that are being treated.
  • If drug enters the eye, the affected eye should be rinsed immediately with plenty of water.

Frequently asked questions

  • Does clobetasol cause hair loss or growth?
  • How do you apply clobetasol propionate for lichen sclerosus?
  • What is clobetasol propionate cream used for?
  • How effective is it for hair growth?
  • How long does it take to work?
  • How do you use clobetasol propionate on your scalp?
  • Can you use clobetasol on your face?
  • Clobetasol vs. triamcinolone - how do they compare?
  • What causes Plaque Psoriasis?
  • Halobetasol vs. clobetasol - how do they compare?
  • Can clobetasol be used for toenail fungus?
  • Can this drug make you gain weight?
  • Can clobetasol propionate be used for poison ivy?
  • How long does clobetasol stay in your system?
  • How long should you use clobetasol propionate cream for?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by